Lipid receptors and islet function: therapeutic implications?
Lipid receptors and islet function: therapeutic implications?
复制标题
DOI:
10.1111/j.1463-1326.2009.01114.x
复制
发表时间:
2009-11
期刊:
影响因子:
--
通讯作者:
Poitout V
中科院分区:
文献类型:
--
作者:
Kebede MA;Alquier T;Latour MG;Poitout V
G-protein coupled receptors (GPCRs) are targets of approximately 30 % of currently marketed drugs. Over the last few years, a number of GPCRs expressed in pancreatic β cells and activated by lipids have been discovered. GPR40 was shown to be activated by medium- to long-chain fatty acids (FAs). It has since been shown that GPR40 contributes to FA amplification of glucose-induced insulin secretion. Although some controversy still exists as to whether GPR40 agonists or antagonists should be designed as novel type 2 diabetes drugs, data obtained in our laboratory and others strongly suggest that GPR40 agonism might represent a valuable therapeutic approach. GPR119 is expressed in pancreatic β cells and enteroendocrine L-cells, and augments circulating insulin levels both via its direct insulinotropic action on β cells and via FA stimulation of glucagon-like peptide 1 (GLP-1) secretion. GPR120 is expressed in L-cells and was also shown to mediate FA-stimulated GLP-1 release. Finally, GPR41 and GPR43 are receptors for short-chain FAs and may indirectly regulate β-cell function via adipokine secretion. While the discovery of these various lipid receptors opens new and exciting avenues of research for drug development, a number of questions regarding their mechanisms of action and physiological roles remain to be answered.
登录
查看更多内容
影响因子:
3.9
作者:
Brownlie, Ruth;Mayers, Rachel M.;Smith, David M.
通讯作者:
Smith, David M.
影响因子:
4.8
作者:
Brown, AJ;Goldsworthy, SM;Dowell, SJ
通讯作者:
Dowell, SJ
影响因子:
3.9
作者:
Covington, D. K.;Briscoe, C. A.;Jayawickreme, C. K.
通讯作者:
Jayawickreme, C. K.
DOI:
10.1152/ajpgi.1998.275.6.g1415
发表时间:
1998-12-01
影响因子:
4.5
作者:
Cherbut, C;Ferrier, L;Galimiche, JP
通讯作者:
Galimiche, JP
影响因子:
4.8
作者:
Feng, DD;Luo, ZQ;Chen, C
通讯作者:
Chen, C